ATLANTA, GA — Andreas Diacon from Stellenbosch University in Cape Town updated the audience at the 2013 CROI on Wednesday about the status and challenges in TB drug development. The good news is that while still inadequate, the TB drug pipeline is larger than it has been in decades.
